Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Micheli

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Chemmedchem|March 23, 2011
Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspectiveFabrizio Micheli
Chemmedchem|April 21, 2017
Novel, Selective, and Developable Dopamine D<sub>3</sub> Antagonists with a Modified "Amino" RegionFabrizio Micheli
Recent Patents on CNS Drug Discovery|January 29, 2008
Selective dopamine D3 receptor antagonists: a review 2001-2005Fabrizio Micheli, Christian Heidbreder
Expert Opinion on Therapeutic Patents|January 4, 2013
Dopamine D3 receptor antagonists: a patent review (2007 - 2012)Fabrizio Micheli, Christian Heidbreder
Pharmaceutical Patent Analyst|November 19, 2013
Triple monoamine uptake inhibitorsAnna Maria Capelli, Fabrizio Micheli
Pain Practice : the Official Journal of World Institute of Pain|March 15, 2021
Factors Predicting Successful Outcome for Ozone Chemonucleolysis in Lumbar Disk HerniationMatteo Luigi Giuseppe Leoni, Annalisa Caruso, Fabrizio Micheli
Bioorganic & Medicinal Chemistry Letters|June 25, 2010
A specific and direct comparison of the trifluoromethyl and pentafluoro sulfanyl groups on the selective dopamine D(3) antagonist 3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane templateFabrizio Micheli, Daniele Andreotti, Simone Braggio, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
Solid-phase synthesis of combinatorial libraries based on enatiomerically pure (1S,2S,4R,5S)-4,5-dihydroxycyclohexan-1,2-dicarboxylic acid scaffoldsDaniela Arosio, Anna Bernardi, Donatella Dellavecchia, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonistsFabrizio Micheli, Marinella Antolini, Romano Di Fabio, et al.
Pain and Therapy|February 17, 2021
Food for Special Medical Purposes and Nutraceuticals for Pain: A Narrative ReviewRoberto Casale, Zaira Symeonidou, Sofia Ferfeli, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Chemmedchem|March 23, 2011
Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspectiveFabrizio Micheli
Chemmedchem|April 21, 2017
Novel, Selective, and Developable Dopamine D<sub>3</sub> Antagonists with a Modified "Amino" RegionFabrizio Micheli
Recent Patents on CNS Drug Discovery|January 29, 2008
Selective dopamine D3 receptor antagonists: a review 2001-2005Fabrizio Micheli, Christian Heidbreder
Expert Opinion on Therapeutic Patents|January 4, 2013
Dopamine D3 receptor antagonists: a patent review (2007 - 2012)Fabrizio Micheli, Christian Heidbreder
Pharmaceutical Patent Analyst|November 19, 2013
Triple monoamine uptake inhibitorsAnna Maria Capelli, Fabrizio Micheli
Pain Practice : the Official Journal of World Institute of Pain|March 15, 2021
Factors Predicting Successful Outcome for Ozone Chemonucleolysis in Lumbar Disk HerniationMatteo Luigi Giuseppe Leoni, Annalisa Caruso, Fabrizio Micheli
Bioorganic & Medicinal Chemistry Letters|June 25, 2010
A specific and direct comparison of the trifluoromethyl and pentafluoro sulfanyl groups on the selective dopamine D(3) antagonist 3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane templateFabrizio Micheli, Daniele Andreotti, Simone Braggio, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
Solid-phase synthesis of combinatorial libraries based on enatiomerically pure (1S,2S,4R,5S)-4,5-dihydroxycyclohexan-1,2-dicarboxylic acid scaffoldsDaniela Arosio, Anna Bernardi, Donatella Dellavecchia, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
2-Methyl-3-furanyl-4H-1,2,4-triazol-3-ylthioamides: a new class of selective orexin 2 antagonistsFabrizio Micheli, Marinella Antolini, Romano Di Fabio, et al.
Pain and Therapy|February 17, 2021
Food for Special Medical Purposes and Nutraceuticals for Pain: A Narrative ReviewRoberto Casale, Zaira Symeonidou, Sofia Ferfeli, et al.
Pageof 7